SCYXSCYNEXIS, Inc.

$38M

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4M-97.3% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$37M-990.8% margin

Net Income

-$21M-568.3% margin

EPS (Diluted)

$-0.44

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$91M

Total Liabilities

$36M

Stockholders' Equity

$55M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$140M	-97.3%
Gross Profit	$4M	$125M	-97.0%
Operating Income	-$37M	$73M	-151.1%
Net Income	-$21M	$67M	-131.8%

SCYX FY 2024 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena